全文获取类型
收费全文 | 106494篇 |
免费 | 42273篇 |
国内免费 | 197篇 |
专业分类
耳鼻咽喉 | 1871篇 |
儿科学 | 5153篇 |
妇产科学 | 1382篇 |
基础医学 | 18399篇 |
口腔科学 | 6181篇 |
临床医学 | 14783篇 |
内科学 | 29335篇 |
皮肤病学 | 8068篇 |
神经病学 | 14553篇 |
特种医学 | 3169篇 |
外国民族医学 | 9篇 |
外科学 | 18926篇 |
综合类 | 904篇 |
现状与发展 | 1篇 |
一般理论 | 46篇 |
预防医学 | 6136篇 |
眼科学 | 2069篇 |
药学 | 7897篇 |
中国医学 | 1164篇 |
肿瘤学 | 8918篇 |
出版年
2023年 | 441篇 |
2022年 | 1252篇 |
2021年 | 3006篇 |
2020年 | 5869篇 |
2019年 | 11821篇 |
2018年 | 11523篇 |
2017年 | 12245篇 |
2016年 | 12950篇 |
2015年 | 12892篇 |
2014年 | 13031篇 |
2013年 | 13854篇 |
2012年 | 6268篇 |
2011年 | 6346篇 |
2010年 | 10052篇 |
2009年 | 6191篇 |
2008年 | 3448篇 |
2007年 | 2397篇 |
2006年 | 2240篇 |
2005年 | 1890篇 |
2004年 | 1832篇 |
2003年 | 1633篇 |
2002年 | 1622篇 |
2001年 | 1256篇 |
2000年 | 1139篇 |
1999年 | 657篇 |
1998年 | 230篇 |
1997年 | 172篇 |
1996年 | 162篇 |
1995年 | 160篇 |
1994年 | 104篇 |
1993年 | 90篇 |
1992年 | 183篇 |
1991年 | 158篇 |
1990年 | 147篇 |
1989年 | 142篇 |
1988年 | 151篇 |
1987年 | 158篇 |
1986年 | 146篇 |
1985年 | 126篇 |
1984年 | 103篇 |
1983年 | 103篇 |
1982年 | 48篇 |
1981年 | 63篇 |
1980年 | 38篇 |
1979年 | 92篇 |
1978年 | 53篇 |
1977年 | 64篇 |
1976年 | 47篇 |
1975年 | 54篇 |
1974年 | 42篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Ahmed Elhassanny Rene Escobedo Daniel Ladin Colin Burns Rukiyah Van Dross 《Oncotarget》2020,11(52):4788
Metastatic melanoma is the most deadly skin neoplasm in the United States. Outcomes for this lethal disease have improved dramatically due to the use of both targeted and immunostimulatory drugs. Immunogenic cell death (ICD) has emerged as another approach for initiating antitumor immunity. ICD is triggered by tumor cells that display damage-associated molecular patterns (DAMPs). These DAMP molecules recruit and activate dendritic cells (DCs) that present tumor-specific antigens to T cells which eliminate neoplastic cells. Interestingly, the expression of DAMP molecules occurs in an endoplasmic reticulum (ER) stress-dependent manner. We have previously shown that ER stress was required for the cytotoxic activity of the endocannabinoid metabolite, 15-deoxy, Δ12,14 prostamide J2 (15dPMJ2). As such, the current study investigates whether 15dPMJ2 induces DAMP signaling in melanoma. In B16F10 cells, 15dPMJ2 caused a significant increase in the cell surface expression of calreticulin (CRT), the release of ATP and the secretion of high-mobility group box 1 (HMGB1), three molecules that serve as surrogate markers of ICD. 15dPMJ2 also stimulated the cell surface expression of the DAMP molecules, heat shock protein 70 (Hsp70) and Hsp90. In addition, the display of CRT and ATP was increased by 15dPMJ2 to a greater extent in tumorigenic compared to non-tumorigenic melanocytes. Consistent with this finding, the activation of bone marrow-derived DCs was upregulated in co-cultures with 15dPMJ2-treated tumor compared to non-tumor melanocytes. Moreover, 15dPMJ2-mediated DAMP exposure and DC activation required the electrophilic cyclopentenone double bond within the structure of 15dPMJ2 and the ER stress pathway. These results demonstrate that 15dPMJ2 is a tumor-selective inducer of DAMP signaling in melanoma. 相似文献
92.
93.
94.
95.
96.
Letter: faecal volatile organic metabolites,promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors’ reply 下载免费PDF全文
I. Ahmed R. Greenwood B. Costello N. Ratcliffe C. Probert 《Alimentary pharmacology & therapeutics》2016,43(11):1241-1242
97.
98.
99.
Fardin Moradi Vahid Maleki Sevda Saleh‐Ghadimi Fatemeh Kooshki Bahram Pourghassem Gargari 《Clinical and experimental pharmacology & physiology》2019,46(11):975-983
Diabetes, as a low‐grade chronic inflammatory disease, causes disruption in proper function of immune and metabolic system. Chromium is an important element required for normal lipid and glucose metabolism. Chromium deficiency is correlated with elevation in cardiometabolic risk, which results from increased inflammation. This systematic review was conducted to discover the potential roles of chromium on inflammatory biomarkers. Eligible studies were all in vitro, animal and human studies published in English‐language journals from inception until October 2018. PubMed, Scopus, Embase, ProQuest and Google Scholar databases were searched to fined interventional studies from the effects of chromium on inflammatory biomarkers such as tumour necrosis factor a (TNF‐a), C‐reactive protein (CRP), interleukins, monocyte chemoattractant protein–1 (MCP‐1), intercellular adhesion molecule‐1 (ICAM‐1) and adipocytokines in hyperglycaemia and diabetes. Out of 647 articles found in the search, only 14 articles were eligible for analysis, three in vitro studies, eight animal studies and three human studies. Twelve of the 14 studies included in this review, chromium significantly decreased inflammatory factors. The findings of this review indicate, based on in vitro and in vivo studies, that chromium might have potential anti‐inflammatory properties, but some of the studies did not show anti‐inflammatory effects for chromium (two studies). There are only three studies in humans with controversial results. Therefore, more consistent randomized double‐blind controlled trials are needed to reach relevant clinical recommendations, as well as to determine the precise mechanism, of chromium on inflammation in diabetes. 相似文献
100.